CVE-2025-5389

JeeWMS File generateController.do dogenerateOne2Many access control

Description

A vulnerability, which was classified as critical, has been found in JeeWMS up to 20250504. Affected by this issue is the function dogenerateOne2Many of the file /generateController.do?dogenerateOne2Many of the component File Handler. The manipulation leads to improper access controls. The attack may be launched remotely. Continious delivery with rolling releases is used by this product. Therefore, no version details of affected nor updated releases are available.

Category

5.3
CVSS
Severity: Medium
CVSS 4.0 •
CVSS 3.1 •
CVSS 2.0 •
EPSS 0.03%
Affected: n/a JeeWMS
Published at:
Updated at:

References

Link Tags
https://vuldb.com/?id.310682 vdb entry technical description
https://vuldb.com/?ctiid.310682 permissions required signature
https://gitee.com/erzhongxmu/JEEWMS/issues/IC5FNV issue tracking

Frequently Asked Questions

What is the severity of CVE-2025-5389?
CVE-2025-5389 has been scored as a medium severity vulnerability.
How to fix CVE-2025-5389?
To fix CVE-2025-5389, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2025-5389 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2025-5389 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2025-5389?
CVE-2025-5389 affects n/a JeeWMS.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.